Last 48 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
National Health Investors, Inc.'s quarterly P/E stands at 23.9x, up 30.9% year-over-year — indicating the stock has re-rated higher or earnings have softened.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 27.84 | 23.87 | 28.80 | 22.19 | 24.95 | 18.24 | 32.33 | 20.90 | 22.12 | 18.87 | 18.88 | 14.24 | 71.64 |
| — | +30.9% | -10.9% | +6.1% | +12.8% | -3.3% | +71.2% | +46.8% | -69.1% | -93.8% | +4.2% | -76.5% | — | |
| P/S Ratio | 10.81 | 0.02 | 10.53 | 9.05 | 9.49 | 9.18 | 11.14 | 8.68 | 8.37 | 7.62 | 6.95 | 7.30 | 6.79 |
| — | -99.7% | -5.5% | +4.3% | +13.4% | +20.4% | +60.2% | +18.9% | +23.2% | -4.9% | -15.4% | -36.9% | -28.4% | |
| P/B Ratio | 2.59 | 2.35 | 2.53 | 2.19 | 2.35 | 2.27 | 2.96 | 2.34 | 2.15 | 1.90 | 1.74 | 1.76 | 1.74 |
| — | +3.3% | -14.8% | -6.1% | +9.0% | +19.5% | +70.4% | +32.5% | +23.9% | +8.3% | -8.0% | -10.1% | -4.4% | |
| P/FCF | 17.17 | — | 16.44 | 13.98 | 18.23 | 13.80 | 19.01 | 12.67 | 17.63 | 11.64 | 11.46 | 11.78 | 19.35 |
| — | — | -13.5% | +10.3% | +3.4% | +18.5% | +65.8% | +7.5% | -8.9% | -3.6% | -21.4% | -8.0% | +10.7% | |
| EV / EBITDA | -0.19 | -0.05 | 18.72 | 15.98 | 16.84 | 17.33 | 18.74 | 15.27 | 15.36 | 14.29 | 13.39 | 14.08 | 13.28 |
| — | -100.3% | -0.1% | +4.6% | +9.7% | +21.3% | +39.9% | +8.5% | +15.6% | -10.3% | -11.2% | -36.8% | -21.2% | |
| EV / EBIT | — | — | 26.40 | 21.59 | 23.93 | 18.81 | 28.47 | 20.80 | 21.57 | 19.25 | 19.33 | 15.99 | 17.86 |
| — | — | -7.3% | +3.8% | +11.0% | -2.3% | +47.3% | +30.1% | +20.8% | -69.6% | -3.2% | -47.1% | -67.6% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
National Health Investors, Inc.'s operating margin was 0.1% in Q4 2025, down 48.9 pp QoQ and down 49.9 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 39.1% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 99.8% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | 0.2% | 97.1% | 96.8% | 96.8% | 96.7% | 96.6% | 96.7% | 96.6% | 96.5% | 96.4% | 95.9% | 96.8% |
| — | -99.8% | +0.5% | +0.1% | +0.1% | +0.2% | +0.3% | +0.9% | -0.2% | -0.3% | -0.6% | -0.5% | +1.1% | |
| Operating Margin | — | 0.1% | 49.1% | 53.7% | 53.6% | 50.0% | 56.1% | 57.9% | 55.5% | 56.3% | 56.3% | 54.6% | 56.3% |
| — | -99.7% | -12.5% | -7.2% | -3.5% | -11.1% | -0.5% | +6.0% | -1.4% | +10.6% | +2.1% | +29.5% | +0.8% | |
| Net Margin | 37797.0% | 383.0% | 36.6% | 40.8% | 38.3% | 50.4% | 34.4% | 41.5% | 38.0% | 40.3% | 36.6% | 51.1% | 41.9% |
| — | +659.5% | +6.3% | -1.7% | +0.8% | +25.0% | -6.1% | -18.8% | -9.3% | +1429.7% | -18.9% | +41.2% | +255.5% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9741.4% | 9370.0% | 2.2% | 2.5% | 2.4% | 3.3% | 2.3% | 2.8% | 2.4% | 2.5% | 2.3% | 3.1% | 2.7% |
| — | +285128.2% | -3.5% | -9.7% | -0.8% | +31.0% | -0.4% | -9.7% | -9.0% | +1661.7% | -9.3% | +106.5% | +378.6% | |
| ROA | 93.3% | 93.2% | 1.2% | 1.4% | 1.3% | 1.7% | 1.2% | 1.4% | 1.2% | 1.3% | 1.2% | 1.6% | 1.4% |
| — | +5367.5% | +5.5% | -5.1% | +1.6% | +32.6% | -1.5% | -10.0% | -8.9% | +1629.5% | -13.2% | +96.6% | +359.4% | |
| ROIC | — | — | 1.3% | 1.4% | 1.4% | 1.3% | 1.5% | 1.5% | 1.4% | 1.4% | 1.4% | 1.3% | 1.4% |
| — | — | -12.1% | -8.5% | -0.4% | -5.7% | +4.4% | +17.5% | -0.7% | +25.3% | +8.8% | +79.4% | +29.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 6306439.2% YoY to 60410.53x, strengthening the short-term liquidity position.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.74 | 0.75 | 0.87 | 0.83 | 0.91 | 0.90 | 0.90 | 0.89 | 0.89 | 0.88 | 0.91 |
| — | — | -18.8% | -16.9% | -2.7% | -7.1% | +1.9% | +2.2% | -1.5% | +0.1% | +6.3% | +12.5% | +8.8% | |
| Debt / EBITDA | — | — | 17.25 | 16.31 | 18.84 | 18.61 | 17.68 | 17.05 | 18.15 | 18.35 | 18.27 | 18.84 | 18.37 |
| — | — | -2.4% | -4.3% | +3.8% | +1.4% | -3.2% | -9.5% | -1.2% | -14.8% | -2.3% | -26.6% | -14.5% | |
| Current Ratio | 60410.53 | 60410.53 | 2.09 | 0.82 | 0.97 | 0.96 | 0.90 | 1.13 | 1.19 | 1.16 | 1.05 | 1.08 | 0.41 |
| — | +6306439.2% | +131.3% | -28.0% | -18.3% | -17.2% | -13.9% | +5.1% | +192.3% | -66.2% | -79.9% | -80.4% | -95.5% | |
| Quick Ratio | 60410.53 | 60410.53 | 2.09 | 0.82 | 0.97 | 0.96 | 0.90 | 1.13 | 1.19 | 1.16 | 1.05 | 1.08 | 0.41 |
| — | +6306439.2% | +131.3% | -28.0% | -18.3% | -17.2% | -13.9% | +5.1% | +192.3% | -66.2% | -79.9% | -80.4% | -95.5% | |
| Interest Coverage | — | 3.58 | — | 3.46 | 3.34 | 3.06 | 3.11 | 3.52 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonNational Health Investors, Inc.'s current P/E is 27.8x. The average P/E over the last 4 quarters is 25.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking National Health Investors, Inc.'s business trajectory between earnings reports.